Study to Determine How BCX4161 is Metabolized and Eliminated by the Body
Clinical trial NCT02218294 · COMPLETED
Trial details
- NCT number
- NCT02218294
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2014-09-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.